APA

Xie X., Liu K., Liu F., Chen H., Wang X., Zu X., Ma X., Wang T., Wu Q., Zheng Y., Bode A. M., Dong Z. & Kim D. J. (20191104). Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. : Cancer letters.

Chicago

Xie Xiaomeng, Liu Kangdong, Liu Feifei, Chen Hanyong, Wang Xiangyu, Zu Xueyin, Ma Xiaoli, Wang Ting, Wu Qiong, Zheng Yan, Bode Ann M, Dong Zigang and Kim Dong Joon. 20191104. Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. : Cancer letters.

Harvard

Xie X., Liu K., Liu F., Chen H., Wang X., Zu X., Ma X., Wang T., Wu Q., Zheng Y., Bode A. M., Dong Z. and Kim D. J. (20191104). Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. : Cancer letters.

MLA

Xie Xiaomeng, Liu Kangdong, Liu Feifei, Chen Hanyong, Wang Xiangyu, Zu Xueyin, Ma Xiaoli, Wang Ting, Wu Qiong, Zheng Yan, Bode Ann M, Dong Zigang and Kim Dong Joon. Gossypetin is a novel MKK3 and MKK6 inhibitor that suppresses esophageal cancer growth in vitro and in vivo. : Cancer letters. 20191104.